- Home
- LSE vs COEP Comparison
LSE vs COEP Comparison
Compare LSE & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSE | COEP |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | China | United States |
| Employees | N/A | 7 |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.4M | 72.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LSE | COEP |
|---|---|---|
| Price | $4.63 | $11.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.8K | ★ 31.9K |
| Earning Date | 02-13-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $61.76 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.80 | $6.32 |
| 52 Week High | $9.78 | $21.41 |
Technical Indicators
Market Signals| Indicator | LSE | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 37.14 |
| Support Level | $4.11 | $8.95 |
| Resistance Level | $5.43 | $13.23 |
| Average True Range (ATR) | 0.61 | 0.97 |
| MACD | -0.07 | -0.10 |
| Stochastic Oscillator | 0.42 | 4.83 |
Price Performance
Historical ComparisonAbout LSE Leishen Energy Holding Co. Ltd. Ordinary Shares
Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.